Clinical Significance: Carbamazepine is an anticonvusant and mood stabalizing drug used in the treatment of epilepsy and neuropathic pain.
Tested in urine only
Drug Class
Anticonvulsants
Metabolite(s)
Carbamazepine Epoxide
Aliases
Tegretol
Methodology
Liquid Chromatography Mass Spectrometry
Urine Recommended Volume
30mL
Oral Fluid Minimum Volume
1mL
Specimen Stability
15 days
Urine Reportable Range
40-1000
Oral Fluid Reportable Range
12-300
Urine Immunoassay Cutoff (ng/mL)
N/A
Urine Window of Detection
1-3 days
Oral Fluid Window of Detection
1-3 days
Rejection Criteria
Quantity Not Sufficient or Wrong Collection Device (Oral Fluid)
Urine Transient Contanier
Urine Clinical Drug Test Transport Cup
Oral Fluid Transient Contanier
Oral Fluid Intercept 2.0 Devices